Abstract
Osteoarthritis (OA) is a systemic joint degenerative disease involving a variety of cytokines and growth factors. In this study, we investigated the protective effect of fibroblast growth factor 1 (FGF1) knockdown on OA and its underlying mechanisms in vitro. In addition, we evaluated the effect of FGF1 knockout on the destabilization of the medial meniscus (DMM) and examined the anterior and posterior cruciate ligament model in vivo. FGF1 affects OA cartilage destruction by increasing the protein expression of Nuclear factor E2-related factor 2 (Nrf2) and heme oxygenase 1 (HO-1), which is associated with the phosphorylation of AMPK and its substrates. Our study showed that FGF1 knockdown could reverse the oxidative damage associated with osteoarthritis. Nrf2 knockdown eliminated the antioxidant effect of FGF1 knockdown on chondrocytes. Furthermore, AMPK knockdown could stop the impact of FGF1 knockdown on osteoarthritis. These findings suggested that FGF1 knockdown could effectively prevent and reverse osteoarthritis by activating AMPK and Nrf2 in articular chondrocytes.
Similar content being viewed by others
Data availability
The corresponding author’s data supporting this study’s funding are available upon reasonable request.
References
Abramoff B, Caldera FE (2020) Osteoarthritis: pathology, diagnosis, and treatment options. Med Clin N Am 104:293–311
Ansari MY, Ahmad N, Haqqi TM (2020) Oxidative stress and inflammation in osteoarthritis pathogenesis: role of polyphenols. Biomed Pharmacother 129:110452
Bindu S, Mazumder S, Bandyopadhyay U (2020) Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: a current perspective. Biochem Pharmacol 180:114147
Conaghan PG, Cook AD, Hamilton JA, Tak PP (2019) Therapeutic options for targeting inflammatory osteoarthritis pain. Nat Rev Rheumatol 15:355–363
Culley KL, Dragomir CL, Chang J, Wondimu EB, Coico J, Plumb DA, Otero M, Goldring MB (2015) Mouse models of osteoarthritis: surgical model of posttraumatic osteoarthritis induced by destabilization of the medial meniscus. Methods Mol Biol 1226:143–173
Ebrahim HA, Alzamil NM, Al-Ani B, Haidara MA, Kamar SS, Dawood AF (2022) Suppression of knee joint osteoarthritis induced secondary to type 2 diabetes mellitus in rats by resveratrol: role of glycated haemoglobin and hyperlipidaemia and biomarkers of inflammation and oxidative stress. Arch Physiol Biochem 128:1375–1382
El-Seoudi A, Abd El Kader T, Nishida T, Eguchi T, Aoyama E, Takigawa M, Kubota S (2017) Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis. J Cell Commun Signal 11:255–263
Feng K, Ge Y, Chen Z, Li X, Liu Z, Li X, Li H, Tang T, Yang F, Wang X (2019) Curcumin inhibits the PERK-eIF2α-CHOP pathway through promoting SIRT1 expression in oxidative stress-induced rat chondrocytes and ameliorates osteoarthritis progression in a rat model. Oxid Med Cell Longev 2019:8574386
Gerwin N, Bendele AM, Glasson S, Carlson CS (2010) The OARSI histopathology initiative—recommendations for histological assessments of osteoarthritis in the rat. Osteoarthr Cartil 18:S24–S34
Hawker GA (2019) Osteoarthritis is a serious disease. Clin Exp Rheumatol 37(Suppl 120):3–6
Hua X, Sun DY, Zhang WJ, Fu JT, Tong J, Sun SJ, Zeng FY, Ouyang SX, Zhang GY, Wang SN, Li DJ, Miao CY, Wang P (2021) P7C3-A20 alleviates fatty liver by shaping gut microbiota and inducing FGF21/FGF1, via the AMP-activated protein kinase/CREB regulated transcription coactivator 2 pathway. Br J Pharmacol 178:2111–2130
Jadeja RN, Jones MA, Abdelrahman AA, Powell FL, Thounaojam MC, Gutsaeva D, Bartoli M, Martin PM (2020) Inhibiting microRNA-144 potentiates Nrf2-dependent antioxidant signaling in RPE and protects against oxidative stress-induced outer retinal degeneration. Redox Biol 28:101336
Latourte A, Kloppenburg M, Richette P (2020) Emerging pharmaceutical therapies for osteoarthritis. Nat Rev Rheumatol 16:673–688
Li L, Luo W, Qian Y, Zhu W, Qian J, Li J, Jin Y, Xu X, Liang G (2019) Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. Phytomed Int J Phytother Phytopharmacol 59:152774
Madhavi YV, Gaikwad N, Yerra VG, Kalvala AK, Nanduri S, Kumar A (2019) Targeting AMPK in diabetes and diabetic complications: energy homeostasis, autophagy and mitochondrial health. Curr Med Chem 26:5207–5229
Mao Y, Liu XQ, Song Y, Zhai CG, Xu XL, Zhang L, Zhang Y (2020) Fibroblast growth factor-2/platelet-derived growth factor enhances atherosclerotic plaque stability. J Cell Mol Med 24:1128–1140
Nishimura R, Hata K, Takahata Y, Murakami T, Nakamura E, Ohkawa M, Ruengsinpinya L (2020) Role of signal transduction pathways and transcription factors in cartilage and joint diseases. Int J Mol Sci 21:1340
Okumura N, Kawasaki T, Kubo M, Yayama T, Mimura T, Kumagai K, Maeda T, Imai S (2020) Effects of malalignment and disease activity on osteophyte formation in knees of rheumatoid arthritis patients. J Orthop Surg (Hong Kong) 28:2309499020911852
Parolini M (2020) Toxicity of the non-steroidal anti-inflammatory drugs (NSAIDs) acetylsalicylic acid, paracetamol, diclofenac, ibuprofen and naproxen towards freshwater invertebrates: a review. Sci Total Environ 740:140043
Pritzker KP, Gay S, Jimenez SA, Ostergaard K, Pelletier JP, Revell PA, Salter D, van den Berg WB (2006) Osteoarthritis cartilage histopathology: grading and staging. Osteoarthr Cartil 14:13–29
Qin A, Zhong T, Zou H, Wan X, Yao B, Zheng X, Yin D (2019) Critical role of Tim-3 mediated autophagy in chronic stress induced immunosuppression. Cell Biosci 9:13
Radi ZA, Khan KN (2019) Cardio-renal safety of non-steroidal anti-inflammatory drugs. J Toxicol Sci 44:373–391
Ren Y, Shen HM (2019) Critical role of AMPK in redox regulation under glucose starvation. Redox Biol 25:101154
Sacitharan PK (2019) Ageing and osteoarthritis. Sub-Cell Biochem 91:123–159
Talaei A, Farkhondeh T, Forouzanfar F (2020) Fibroblast growth factor: promising target for schizophrenia. Curr Drug Targets 21:1344–1353
Tian L, Cao W, Yue R, Yuan Y, Guo X, Qin D, Xing J, Wang X (2019) Pretreatment with Tilianin improves mitochondrial energy metabolism and oxidative stress in rats with myocardial ischemia/reperfusion injury via AMPK/SIRT1/PGC-1 alpha signaling pathway. J Pharmacol Sci 139:352–360
Tu M, Yao Y, Qiao FH, Wang L (2019) The pathogenic role of connective tissue growth factor in osteoarthritis. Biosci Rep 39:374
van den Bosch MHJ (2021) Osteoarthritis year in review 2020: biology. Osteoarthr Cartil 29:143–150
Vincent TL (2019) Mechanoflammation in osteoarthritis pathogenesis. Semin Arthritis Rheum 49:S36-s38
Wang J, Liu S, Li J, Yi Z (2019) The role of the fibroblast growth factor family in bone-related diseases. Chem Biol Drug Des 94:1740–1749
Wu S, Zou MH (2020) AMPK, mitochondrial function, and cardiovascular disease. Int J Mol Sci 21:4987
Wu Y, Jia G, Wang B, Xiong J, Xu J, Zheng P, Yuan Y, Li Y, Jiang T, Al Mamun A, Xu K, Liu Y, Cao H, Xiao J (2020) Fibroblast growth factor 1 ameliorates diabetes-induced splenomegaly via suppressing inflammation and oxidative stress. Biochem Biophys Res Commun 528:249–255
Xie Y, Zinkle A, Chen L, Mohammadi M (2020) Fibroblast growth factor signalling in osteoarthritis and cartilage repair. Nat Rev Rheumatol 16:547–564
Yu J, Wang WN, Matei N, Li X, Pang JW, Mo J, Chen SP, Tang JP, Yan M, Zhang JH (2020) Ezetimibe attenuates oxidative stress and neuroinflammation via the AMPK/Nrf2/TXNIP pathway after MCAO in rats. Oxid Med Cell Longev 2020:4717258
Zahan OM, Serban O, Gherman C, Fodor D (2020) The evaluation of oxidative stress in osteoarthritis. Med Pharm Rep 93:12–22
Zhang L, Wei W (2020) Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther 207:107452
Zhuang Y, Wu H, Wang X, He J, He S, Yin Y (2019) Resveratrol attenuates oxidative stress-induced intestinal barrier injury through PI3K/Akt-mediated Nrf2 signaling pathway. Oxid Med Cell Longev 2019:7591840
Funding
No funding was received.
Author information
Authors and Affiliations
Contributions
LY-X and ZG conceived and designed the study, and acquired data. All authors contributed to data analysis and manuscript preparation. All authors read and approved the final manuscript. All the authors read and approved the final manuscript and agree to be accountable for all aspects of the work.
Corresponding author
Ethics declarations
Competing interests
The authors declare that they have no competing interests.
Ethical approval
All procedures related to the use and care of animals in this study were approved by the ethics committee of Kunming Medical University approved our animal experiment procedure (KMUWECA 20210007).
Patient consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, YX., Shu, J., Kou, Nn. et al. FGF1 reduces cartilage injury in osteoarthritis via regulating AMPK/Nrf2 pathway. J Mol Histol 54, 427–438 (2023). https://doi.org/10.1007/s10735-023-10143-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10735-023-10143-8